BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1986946)

  • 1. Differential development of angiotensin II receptor subtypes in the rat brain.
    Tsutsumi K; Saavedra JM
    Endocrinology; 1991 Jan; 128(1):630-2. PubMed ID: 1986946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-1 and type-2 angiotensin II receptors in fetal rat brain.
    Tsutsumi K; Viswanathan M; Strömberg C; Saavedra JM
    Eur J Pharmacol; 1991 May; 198(1):89-92. PubMed ID: 1717294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of angiotensin II receptor subtype heterogeneity in rat brain.
    Song K; Allen AM; Paxinos G; Mendelsohn FA
    J Comp Neurol; 1992 Feb; 316(4):467-84. PubMed ID: 1577995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of the two subtypes of angiotensin II receptor in rat brain using selective nonpeptide antagonists.
    Leung KH; Smith RD; Pieter ; Timmermans BM; Chiu AT
    Neurosci Lett; 1991 Feb; 123(1):95-8. PubMed ID: 2062460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain.
    Tsutsumi K; Saavedra JM
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R209-16. PubMed ID: 1858948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative autoradiography reveals different angiotensin II receptor subtypes in selected rat brain nuclei.
    Tsutsumi K; Saavedra JM
    J Neurochem; 1991 Jan; 56(1):348-51. PubMed ID: 1987323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function.
    Tsutsumi K; Saavedra JM
    Endocrinology; 1991 Dec; 129(6):3001-8. PubMed ID: 1954884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-peptide angiotensin II receptor antagonists discriminate subtypes of 125I-angiotensin II binding sites in the rat brain.
    Gehlert DR; Gackenheimer SL; Reel JK; Lin HS; Steinberg MI
    Eur J Pharmacol; 1990 Oct; 187(1):123-6. PubMed ID: 2272349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on the selectivity of DuP 753, a nonpeptide angiotensin II receptor antagonist.
    Wong PC; Tam SW; Herblin WF; Timmermans PB
    Eur J Pharmacol; 1991 Apr; 196(2):201-3. PubMed ID: 1651874
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution of angiotensin II receptor subtypes in rat brain nuclei.
    Obermüller N; Unger T; Culman J; Gohlke P; de Gasparo M; Bottari SP
    Neurosci Lett; 1991 Oct; 132(1):11-5. PubMed ID: 1787912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of glomerular angiotensin II receptor subtypes.
    Gauquelin G; Garcia R
    Receptor; 1992; 2(3):207-12. PubMed ID: 1472951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of renal angiotensin II receptors using subtype selective antagonists.
    Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of AT1 and AT2 angiotensin receptors to its cognitive effects.
    Braszko J
    Acta Neurobiol Exp (Wars); 1996; 56(1):49-54. PubMed ID: 8787210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats.
    Haws RM; Shaul PW; Arant BS; Atiyeh BA; Seikaly MG
    Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development.
    Millan MA; Jacobowitz DM; Aguilera G; Catt KJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11440-4. PubMed ID: 1763058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II stimulates phosphoinositide turnover and phosphorylase through AII-1 receptors in isolated rat hepatocytes.
    García-Sáinz JA; Macías-Silva M
    Biochem Biophys Res Commun; 1990 Oct; 172(2):780-5. PubMed ID: 2173579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.